6505--770_Pharmaceuticals_VA CMOP National Office_36C77025Q0135 770-25-2-801-0255 -National CMOP A1222 ACAMPROSATE
ID: 36C77025Q0135Type: Solicitation
Overview

Buyer

VETERANS AFFAIRS, DEPARTMENT OFVETERANS AFFAIRS, DEPARTMENT OFNATIONAL CMOP OFFICE (36C770)LEAVENWORTH, KS, 66048, USA

NAICS

Pharmaceutical Preparation Manufacturing (325412)

PSC

DRUGS AND BIOLOGICALS (6505)

Original Source

https://sam.gov/opp/67e54556fbfd47118e63af790212a26c/view
Timeline
    Description

    The Department of Veterans Affairs is issuing a presolicitation notice for the procurement of Acamprosate pharmaceuticals, specifically 333mg enteric-coated tablets, to support veteran care through the National CMOP. The requirement includes various order quantities totaling between 240 to 720 packages for delivery to multiple locations, emphasizing the need for U.S.-made products in compliance with the Drug Supply Chain Security Act and international trade agreements. This procurement is critical for ensuring rapid and reliable sourcing of essential pharmaceuticals for veterans, with responses due by February 12, 2025, at 9:00 AM CST and an estimated award date of February 18, 2025. Interested vendors should submit complete documentation, including a signed SF1449 cover page, price schedule in Excel, and a state wholesale distributor license, directed to Contract Specialist Michael McAlhaney at Michael.McAlhaney@va.gov or (913) 684-0134.

    Point(s) of Contact
    Michael W McAlhaneyContracting Specialist
    Michael.McAlhaney@va.gov
    Files
    Title
    Posted
    36C77025Q0135_1.docx
    The document outlines a government Request for Proposal (RFP) for pharmaceutical supplies through the Department of Veterans Affairs (VA). The solicitation, identified by number 36C77025Q0135, is aimed at securing drug supplies for the VA's Consolidated Mail Outpatient Pharmacy (CMOP) and emphasizes requirements for sourcing medications compliant with the Drug Supply Chain Security Act (DSCSA). Key details include the need for quotes from contractors, providing necessary documentation such as state distributor licenses and trade agreements certificates. The solicitation specifies delivery standards, including tracking requirements and barcoding, as well as packaging guidelines to ensure safety and compliance with various regulations. Additionally, the project is set aside for small businesses, particularly those owned by veterans and women, showcasing the VA's commitment to supporting these enterprises. The document includes comprehensive sections on pricing, delivery schedules, contract clauses, and compliance with federal regulations governing commercial products and services. The summarized content reflects the essential guidelines and conditions prospective bidders must adhere to when responding to the RFP, ensuring that all pharmaceutical offerings meet the strict standards of quality and reliability demanded by the VA.
    36C77025Q0135.docx
    The Department of Veterans Affairs is issuing a presolicitation notice for an emergency procurement of Acamprosate pharmaceuticals, specifically 333mg enteric-coated tablets, with various order quantities totaling 240 to 720 packages for delivery to multiple locations through the National CMOP. The solicitation number is 36C77025Q0135. Responses are due by February 12, 2025, at 9:00 AM CST, with an estimated award date of February 18, 2025. Vendors must comply with the Drug Supply Chain Security Act and submit complete documentation, including a signed SF1449 cover page, price schedule in Excel, and a state wholesale distributor license. The requirement emphasizes U.S.-made products, reflecting compliance with international trade agreements. The contracting office for this procurement is located in Leavenworth, KS, with all submissions directed to the Contract Specialist, Michael McAlhaney. This presolicitation demonstrates the VA's efforts to ensure rapid and reliable sourcing of critical pharmaceuticals for veteran care.
    52.225-6 TRADE AGREEMENTS CERTIFICATE.docx
    The document, a Trade Agreements Certificate (FAR Provision 52.225-6), outlines certification requirements for offerors in federal procurement processes. It mandates that each end product, except for those specified in paragraph (b), must be U.S.-made or from designated countries. Offerors are required to list any products that do not meet these criteria. The government evaluates offers in alignment with federal acquisition policies, particularly for line items subject to the WTO GPA, allowing evaluation of offers regardless of the Buy American statute restrictions. Only U.S.-made or designated country end products will typically be considered for award unless the Contracting Officer determines that there are insufficient offers for these products. This provision reflects the federal government's commitment to maintaining trade agreements while promoting domestic sourcing in its procurement practices. It serves as a critical component in ensuring compliance with trade regulations within the broader context of federal grants and RFPs for state and local projects.
    S02_Solicitation_Attachment_Pricing SpreadSheet_RFQ_36C77025Q0135.xlsx
    The document outlines a Request for Quotation (RFQ) from the VA's Consolidated Mail Outpatient Pharmacy (CMOP) for the supply of Acamprosate Calcium 333mg EC tablets in various quantities. The RFQ (36C77025Q0135) is expected to be issued on February 5, 2025, with a submission deadline of February 12, 2025, by 9:00 AM CST. The estimated delivery date is set for March 4, 2025. Vendors must comply with the Drug Supply Chain Security Act (DSCSA) and provide their state wholesale distributor license to validate this compliance, as failure to do so will result in disqualification. The document specifies required submissions, including a signed SF1449 form, a price schedule in Excel, and a completed Trade Agreements Certificate. Further administrative contact information is provided for CMOP logistics teams across various locations, emphasizing the critical nature of proper documentation and adherence to established regulations to ensure qualified procurement of the pharmaceutical product. This process reflects the government's commitment to maintaining compliance and securing safe supply chains for medication distribution.
    Similar Opportunities
    6505--Mycophenolate Mofetil RFP
    Buyer not available
    The Department of Veterans Affairs (VA) is preparing to issue a Request for Proposal (RFP) numbered 36E79725R0010 for the procurement of Mycophenolate Mofetil tablets and capsules, intended for use by the VA, Department of Defense (DOD), Bureau of Prisons (BOP), and Indian Health Service (IHS). The procurement aims to secure a reliable source of supply for these essential medications, with a contract term of one year and the option to extend for four additional years, emphasizing the importance of uninterrupted access to critical pharmaceuticals for veterans and associated federal programs. Interested offerors must comply with specific packaging requirements, including child-resistant closures for smaller bottles, and are encouraged to check the designated URL for updates, with the solicitation expected to be issued around February 14, 2025, and offers accepted until February 28, 2025. For inquiries, potential bidders can contact Amber Zavala at amber.zavala@va.gov or by phone at (708) 786-5245.
    6505--Domestic Pharmaceuticals/Med/Surge
    Buyer not available
    The Department of Veterans Affairs is conducting a Sources Sought notice to identify qualified domestic pharmaceutical manufacturers capable of supplying a range of medications for the Consolidated Mail Outpatient Pharmacy (CMOP). The procurement aims to ensure a reliable supply of domestically manufactured pharmaceuticals, including glucose test strips, hypertension treatments, and various other essential medications. This initiative is crucial for maintaining the health and well-being of veterans, as it supports ongoing healthcare needs. Interested manufacturers must submit their capability statements by February 5, 2025, to Josie Linaweaver at josie.linaweaver@va.gov, and are reminded to register in the System for Award Management (SAM) prior to contract award.
    6505--Tamsulosin Capsules
    Buyer not available
    The Department of Veterans Affairs is soliciting proposals for the procurement of Tamsulosin Hydrochloride capsules as part of its Pharmaceutical Prime Vendor (PPV) Programs. Offerors are required to submit pricing for a base year and four option years, ensuring compliance with FDA standards and providing a unique 11-digit National Drug Code (NDC) for each product. This procurement is vital for maintaining a consistent supply of necessary pharmaceuticals to federal healthcare facilities, adhering to regulatory standards while ensuring availability and pricing stability. Interested parties must submit their offers by February 24, 2025, at 2:30 PM CST, and can contact Contract Specialist Andrew J. Cazares at Andrew.Cazares@va.gov for further information.
    3 Line Pharmaceutical Tucson CMOP
    Buyer not available
    The Department of Veterans Affairs (VA) is seeking potential vendors for the provision of domestically manufactured pharmaceuticals as part of the Consolidated Mail Outpatient Pharmacy (CMOP) program, specifically targeting products such as Urea 40% cream and Propranolol HCL capsules in various dosages. This Sources Sought Notice aims to gather input from both small and large businesses to facilitate market research and ensure a well-informed acquisition process, emphasizing compliance with federal requirements and certification standards. Interested parties are encouraged to respond by February 7, 2025, providing company information, confirmation of domestic manufacturing, and pricing details, with all inquiries directed to Sarah Fry at sarah.fry2@va.gov or by phone at 913-758-9935.
    6505--Bevacizumab Injection
    Buyer not available
    The Department of Veterans Affairs (VA) intends to procure Bevacizumab Injections through a Request for Proposal (RFP) designated as 36E79725R0019. This procurement aims to secure an uninterrupted supply of Bevacizumab, a critical pharmaceutical product used in the treatment of various medical conditions, for the VA, Department of Defense (DoD), Bureau of Prisons (BOP), Indian Health Service (IHS), and Federal Health Care Center (FHCC). The contract will span one year with four additional one-year option periods, and the estimated annual requirements include various package sizes of Bevacizumab, with a total estimated usage of over 100,000 vials. Interested offerors must submit their proposals by March 4, 2025, at 2:30 PM Central Time, and can direct inquiries to Contract Specialist Matthew Poulin at Matthew.Poulin@va.gov or by phone at 708-786-5186.
    6505--766-25-1-400-0133 -Charleston CMOP *CS 5A- 2 PHARMACEUTICALS (CONTROLLED SUB) -(VA-25-00022099)
    Buyer not available
    The Department of Veterans Affairs is seeking vendors to provide pharmaceuticals for the Consolidated Mail Outpatient Pharmacy (CMOP) located in Ladson, Charleston, South Carolina. The procurement involves submitting a Request for Quotation (RFQ) for various pharmaceutical products, with specific requirements including valid state wholesale distributor licenses, adherence to the Drug Supply Chain Security Act, and the inclusion of barcodes on all products. This initiative is crucial for ensuring the timely and compliant delivery of medical supplies to support veterans' healthcare needs. Interested vendors must submit their quotes by February 6, 2025, at 3:00 PM Central Time, and can contact Contract Specialist Kelley Cunningham at kelley.cunningham@va.gov for further information.
    6505--Phenytoin SA Capsules (VA-25-00022318)
    Buyer not available
    The Department of Veterans Affairs (VA) intends to issue a Request for Proposal (RFP) for the procurement of Phenytoin Sodium Extended 100MG Sustained Action Capsules, designated as solicitation number 36E79725R0016. This unrestricted contract aims to ensure a reliable supply of these essential medications for the VA, Department of Defense (DOD), Bureau of Prisons (BOP), and Indian Health Service (IHS), with one contract awarded for an initial period of one year and the option for four additional one-year periods. The estimated annual requirement is approximately 16,653 units, highlighting the critical need for uninterrupted supply to support service members and associated organizations. Interested offerors should submit their proposals by March 7, 2025, following the electronic issuance of the RFP on or about February 21, 2025, and may direct inquiries to Contract Specialist Youlanda Duggar at youlanda.duggar@va.gov.
    6505--CAMPHOR/SALICYLATE Sources Sought Notice
    Buyer not available
    The Department of Veterans Affairs is conducting a Sources Sought Notice to identify potential vendors for the supply of Camphor/Menthol/Methyl Salicylate Patch (NDC: 46581-0110-60) for its Tucson Consolidated Mail Outpatient Pharmacy (CMOP). This announcement serves as a Request for Information (RFI) to gather insights on qualified sources capable of distributing these pharmaceuticals, emphasizing the need for vendors to confirm their licensing, registration in SAM.gov, and, if applicable, certification as a Service-Disabled Veteran-Owned Small Business (SD/VOSB) in VETCERT. Responses to this notice will be treated as informational only and will not result in any obligation or entitlement to payment by the government. Interested parties must submit their responses via email to the designated contracting officer, Larry Zaritz, at larry.zaritz@va.gov by 10:00 AM CST on February 7, 2025.
    760-25-1-050-0154 -Leavenworth CMOP THYROID TABLETS -(VA-25-00022614)
    Buyer not available
    The Department of Veterans Affairs is soliciting proposals for the procurement of Armour Thyroid tablets for the Leavenworth Consolidated Mail Outpatient Pharmacy (CMOP) under solicitation number 36C77025Q0079. This Request for Quotation (RFQ) emphasizes the need for specific brand-name pharmaceuticals, with a focus on compliance with federal regulations, including the Drug Supply Chain Security Act and the Buy American Act. The procurement process aims to ensure a reliable supply of essential medications for veterans, with a firm-fixed-price contract expected to be awarded based on fair market evaluations. Interested vendors must submit their quotes by December 27, 2024, at 4:00 PM CST, and can direct inquiries to Jennifer L. Knight at jennifer.knight@va.gov or by phone at 913-684-0162.
    6505--Fluticasone Propionate 50 MCG/Spray Soln, Nasal, 16GM
    Buyer not available
    The Department of Veterans Affairs (VA) is preparing to issue a Request for Proposal (RFP) for the procurement of Fluticasone Propionate 50 MCG/Spray solution, nasal, 16GM, intended for use by various federal agencies including the Department of Defense, Bureau of Prisons, and Indian Health Service. The objective of this procurement is to secure a reliable and uninterrupted supply of this medication for a contract period of one year, with the possibility of four additional one-year extensions. This medication is crucial for treating nasal conditions, and the estimated annual requirement is approximately 5,784,828 bottles. The solicitation will be available electronically on or around February 11, 2025, with a closing date set for February 25, 2025. Interested vendors should direct inquiries to Michael Olszewski at michael.olszewski@va.gov or call 708-786-4966.